2B01 Eschelman, David J. - Thomas Jefferson University - Thomas Jefferson University
dje101

David Eschelman, MD, FSIR

Contact Dr. Eschelman

132 South 10th Street
Suite 766E, Main Building
Philadelphia, PA 19107

(215) 955-7304
(215) 923-6754 fax

Most Recent Peer-reviewed Publications

  1. A phantom study and a retrospective clinical analysis to investigate the impact of a new image processing technology on radiation dose and image quality during hepatic embolization
  2. Yttrium-90 microsphere brachytherapy for liver metastases from uveal melanoma clinical outcomes and the predictive value of fluorodeoxyglucose positron emission tomography
  3. Arterial Blood, Rather Than Venous Blood, is a Better Source for Circulating Melanoma Cells
  4. Double-blinded, randomized phase II study using embolization with or without granulocyte-macrophage colony-stimulating factor in uveal melanoma with hepatic metastases
  5. Uveal melanoma metastatic to the liver: Chemoembolization with 1,3-bis-(2-chloroethyl)-1-nitrosourea
  6. Early arterial stasis during resin-based yttrium-90 radioembolization: Incidence and preliminary outcomes
  7. Transhepatic therapies for metastatic uveal melanoma
  8. Single-center comparison of three chemoembolization regimens for hepatocellular carcinoma
  9. Combined hepatic arterial embolization and hepatic ablation for unresectable colorectal metastases to the liver
  10. Radiation emission from patients treated with selective hepatic radioembolization using yttrium-90 microspheres: Are contact restrictions necessary?
  11. Toxicities after radioembolization with yttrium-90 SIR-spheres: Incidence and contributing risk factors at a single center
  12. Moxifloxacin prophylaxis for chemoembolization or embolization in patients with previous biliary interventions: A pilot study
  13. Side-branch embolization before 90Y radioembolization: Rate of recanalization and new collateral development
  14. The use of a covered stent in carotid blowout syndrome
  15. Radioembolization as salvage therapy for hepatic metastasis of uveal melanoma: A single-institution experience
  16. High-dose immunoembolization: Survival benefit in patients with hepatic metastases from uveal melanoma
  17. Immunoembolization of malignant liver tumors, including uveal melanoma, using granulocyte-macrophage colony-stimulating factor
  18. A five-year, retrospective, comparison review of survival in neurosurgical patients diagnosed with venous thromboembolism and treated with either inferior vena cava filters or anticoagulants
  19. Successful aortic fenestration to treat prolonged motor paralysis of the lower extremities after repair of type a aortic dissection
  20. Infectious Complications of Implantable Venous Access Devices in Patients with Sickle Cell Disease
0